BIA
CDMO

Bell Investment Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bell Investment Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26
Closed – – 2046
2022
Q3 		$0 Buy
+26
New +$474 ﹤0.01% 2003

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bell Investment Advisors's CDMO Position: Q4 2022 in Review

Bell Investment Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 26 shares.

Bell Investment Advisors first reported a position in CDMO in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Bell Investment Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bell Investment Advisors sold 26 Avid Bioservices, Inc. Common Stock shares in Q4 2022.
  • Bell Investment Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Bell Investment Advisors's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Bell Investment Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.